Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis

Therapeutic Apheresis

Volumn 1, Issue 4, 1997, Pages 356-361

  Kojima, Shunichi ^a   Ogi, Makoto ^a   Sugi, Toshihiko ^a   Matsumoto, Yuji ^a   Yoshitomi, Yuji ^a   Kuramochi, Morio ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

Apheresis; Bradykinin; Dextran sulfate; Endothelium derived relaxant factor; Low density lipoprotein; Nitric oxide

Indexed keywords

BRADYKININ; DEXTRAN SULFATE; KALLIKREIN; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE;

AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALE; METABOLISM; MIDDLE AGED; PLASMAPHERESIS;

AGED; BRADYKININ; DEXTRAN SULFATE; FEMALE; HUMANS; KALLIKREINS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NITRIC OXIDE; PLASMAPHERESIS;

EID: 0031261266     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-9987.1997.tb00055.x     Document Type: Article

References (20)

1. Kojima S, Harada-Shiba M, Nomura S, Kimura G, Tsushima M, Kuramochi M, Yamamoto A, Omae T. Effect of nafamostat mesilate on bradykinin generation during low-density lipoprotein apheresis using a dextran sulfate cellulose column. ASAIO Trans 1991;37:644-8.
2. McCarthy DA, Potter DE, Nicolaides ED. An in vivo estimation of the potencies and half-lives of synthetic bradykinin and kallidin. J Pharmacol Exp Ther 1965;148:117-22.
3. Olbricht CJ, Schaumann D, Fischer D. Anaphylactoid reactions, DS LDL apheresis with dextran sulphate, and ACE inhibitor. Lancet 1993;341:908-9.
4. Yang HYT, Erdos EG, Levin Y. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta 1970;214:374-6.
5. Furchgott RF. The requirement of endothelial cells in the relaxation of the arteries by acetylcholine and some other vasodilators. Trends Pharmacol Sci 1981;3:175.
6. Toda N, Okamura T. Endothelium-dependent and -independent responses to vasoactive substances of isolated human coronary arteries. Am J Physiol 1989;257:H988-95.
7. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333: 664-6.
8. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arterial tone in man. Lancet 1989;2:997-1000.
9. Tani N. Development of selective adsorbent and DS LDL apheresis system: Immobilized polyanions as LDL-specific adsorbent for DS LDL apheresis system. J Jpn Atheroscl Soc 1990;18:173-81.
10. Aoyama T, Ino Y, Ozeki M, Oda M, Sato T, Koshiyama Y, Suzuki S, Fujita M. Pharmacological studies of FUT-175, nafamostat mesilate. I. Inhibition of protease activity in vitro and in vivo experiments. Jpn J Pharmacol 1984;35:203-27.
11. Shimamoto K, Ando T, Tanaka S, Nakahashi Y, Nishitani T, Hosoda S, Ishida H, Iimura O. An improved method for the determination of human blood kinin levels by sensitive kinin radioimmunoassay. Endocrinol Jpn 1982;29:487-94.
12. 15N]-nitrate in biological fluids. Analyt Biochem 1982;126:131-8.
13. Kojima S, Ogi M, Yoshitomi Y, Kuramochi M, Ikeda J, Naganawa M, Hatakeyama H. Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density lipoprotein apheresis. Int J Artif Organs 1997;20: 178-83.
14. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
15. Oshima H, Tsuda M, Adachi H, Ogura T, Sugimura T, Esumi H. L-arginine-dependent formation of N-nitrosamines by the cytosol of macrophages activated with lipopolysaccharide and interferon-γ. Cacinogenesis 1991;12:1217-20.
16. Davidson DC, Peart I, Turner S, Sangster M. Prevention with icatibant of anaphylactoid reactions to ACE inhibitor during DS LDL apheresis. Lancet 1994;343:1575.
17. Busse R, Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 1990; 275:87-90.
18. Rimele TJ, Sturm RJ, Adams LM, Henry DE, Heaslip RJ, Weichman BM, Grimes D. Interaction of neutrophils with vascular smooth muscle: Identification of a neutrophil-derived relaxing factor. J Pharmacol Exp Ther 1988;245: 102-11.
19. Boulanger C, Schini VB, Moncada S, Vanhoutte PM. Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide. Br J Pharmacol 1990;101: 152-6.
20. Emori T, Hirata Y, Kanno K, Ohta K, Eguchi S, Imai T, Marumo F. Endothelin-3 stimulates production of an L-arginine-derived nitric oxide via phosphoinositide breakdown. Biochem Biophys Res Commun 1991;174:228-35.